Houlihan Financial Resource Group’s Elevance Health ELV Stock Holding History

Houlihan Financial Resource Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$69K	Buy	+212	New	+$57K	0.04%	150

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Houlihan Financial Resource Group's ELV Position: Q3 2020 in Review

Houlihan Financial Resource Group opened a new position in Elevance Health (ELV) in Q3 2020: 212 shares worth $69K. The stake represents 0.04% of the portfolio and ranks #150 among its holdings.

1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

Houlihan Financial Resource Group held 212 shares of Elevance Health worth $69K as of Q3 2020.
Elevance Health was a new Houlihan Financial Resource Group position in Q3 2020.
Elevance Health made up 0.04% of Houlihan Financial Resource Group's portfolio in Q3 2020, its #150 holding.
1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on Houlihan Financial Resource Group's 13F filing for Q3 2020, filed 13 Nov 2020.